Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval

Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179667
Contributor : Laurent Jonchère <>
Submitted on : Thursday, July 11, 2019 - 9:24:37 AM
Last modification on : Monday, August 26, 2019 - 10:22:24 AM

Identifiers

Citation

Tristan Pascart, Laurène Norberciak, Hang-Korng Ea, Sahara Graf, Pascal Guggenbuhl, et al.. Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval. Rheumatology, Oxford University Press (OUP), 2019, ⟨10.1093/rheumatology/kez203⟩. ⟨hal-02179667⟩

Share

Metrics

Record views

16